Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Jul 21. pii: S0360-3016(15)00552-0. doi: 10.1016/j.ijrobp.2015.05.024. [Epub ahead of print]

PMID:
26209502
2.

TH-AB-BRB-09: Effect of Hydrogel Spacer On Achievable Rectal DVH for IMRT in Prostate Cancer.

Bosch W, Olsen L, Straube W, DeWees T, Mariados N, Sylvester J, Shah D, Kurtzman S, Zimberg S, Michalski J.

Med Phys. 2015 Jun;42(6):3706. doi: 10.1118/1.4926140.

PMID:
26129441
3.

WE-G-BRB-04: Leveraging Innovation to Design Future Clinical Trials.

Michalski J.

Med Phys. 2015 Jun;42(6):3690. doi: 10.1118/1.4926070.

PMID:
26129367
4.

SU-E-P-22: AAPM Task Group 263 Tackling Standardization of Nomenclature for Radiation Therapy.

Matuszak M, Moran J, Xiao Y, Mayo C, Bosch W, Popple R, Marks L, Wu Q, Molineu A, Miller R, Yock T, McNutt T, Brown N, Purdie T, Yorke E, Santanam L, Gabriel P, Michalski J, Moore J, Richardson S, Siochi R, Napalitano M, Ulin K, Fitzgerald T, Feng M, Verbakel W, Siddiqui S, Morgas T, Martel M, Archambault Y, Ladra M, Lansing B, Ruo R, Fogliata-Cozzi A, Hurkmans C.

Med Phys. 2015 Jun;42(6):3231. doi: 10.1118/1.4923956.

PMID:
26127263
5.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):863-73. doi: 10.1016/j.ijrobp.2015.03.017. Epub 2015 Mar 25.

PMID:
26104939
6.

Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a (60)Co Magnetic Resonance Image Guidance Radiation Therapy System.

Wooten HO, Green O, Yang M, DeWees T, Kashani R, Olsen J, Michalski J, Yang D, Tanderup K, Hu Y, Li HH, Mutic S.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):771-8. doi: 10.1016/j.ijrobp.2015.02.057. Epub 2015 Mar 17.

PMID:
26104932
7.

Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Hamstra DA, Bosch W, Gay H, Michalski J.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7. doi: 10.1016/j.ijrobp.2015.04.030. Epub 2015 Apr 23.

8.

Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.

Awad K, Griffin J, Crawford TC, Lane Cox S, Ferrick K, Mazur A, Pena RE, Lloyd SG, Michalski J, Johnson W, Bailey WM.

Heart Rhythm. 2015 Jun 3. pii: S1547-5271(15)00692-X. doi: 10.1016/j.hrthm.2015.06.002. [Epub ahead of print]

PMID:
26049048
9.

Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.

Moore KL, Schmidt R, Moiseenko V, Olsen LA, Tan J, Xiao Y, Galvin J, Pugh S, Seider MJ, Dicker AP, Bosch W, Michalski J, Mutic S.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):228-35. doi: 10.1016/j.ijrobp.2015.01.046. Epub 2015 Apr 3.

PMID:
25847605
10.

Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.

Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM.

Cancer. 2015 May 15;121(10):1694-702. doi: 10.1002/cncr.29209. Epub 2015 Jan 29.

PMID:
25641407
11.

Prostaglandin E2 switches from a stimulator to an inhibitor of cell migration after epithelial-to-mesenchymal transition.

Li YJ, Kanaji N, Wang XQ, Sato T, Nakanishi M, Kim M, Michalski J, Nelson AJ, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI.

Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:1-9. doi: 10.1016/j.prostaglandins.2014.10.003. Epub 2014 Oct 31.

PMID:
25460827
12.

Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer.

Markovina S, Weschenfelder DC, Gay H, McCandless A, Carey B, DeWees T, Knutson N, Michalski J.

Pract Radiat Oncol. 2014 Nov-Dec;4(6):430-6. doi: 10.1016/j.prro.2014.02.004. Epub 2014 May 17.

PMID:
25407866
13.

Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes.

Kanaji N, Basma H, Nelson A, Farid M, Sato T, Nakanishi M, Wang X, Michalski J, Li Y, Gunji Y, Feghali-Bostwick C, Liu X, Rennard SI.

Am J Physiol Lung Cell Mol Physiol. 2014 Sep 1;307(5):L364-73. doi: 10.1152/ajplung.00041.2014. Epub 2014 Jul 11.

PMID:
25015975
14.

Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations.

Varma N, Michalski J, Stambler B, Pavri BB; TRUST Investigators.

Eur Heart J. 2014 May 21;35(20):1345-52. doi: 10.1093/eurheartj/ehu066. Epub 2014 Mar 3.

15.

Reprogramming of COPD lung fibroblasts through formation of induced pluripotent stem cells.

Basma H, Gunji Y, Iwasawa S, Nelson A, Farid M, Ikari J, Liu X, Wang X, Michalski J, Smith L, Iqbal J, El Behery R, West W, Yelamanchili S, Rennard D, Holz O, Mueller KC, Magnussen H, Rabe K, Castaldi PJ, Rennard SI.

Am J Physiol Lung Cell Mol Physiol. 2014 Mar 15;306(6):L552-65. doi: 10.1152/ajplung.00255.2013. Epub 2014 Jan 31.

16.

Influence of static and alternating magnetic fields on U937 cell viability.

Wócik-Piotrowicz K, Kaszuba-Zwoińska J, Rokita E, Thor P, Chrobik P, Nieckarz Z, Michalski J.

Folia Med Cracov. 2014;54(4):21-33.

17.

Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups.

Merks JH, De Salvo GL, Bergeron C, Bisogno G, De Paoli A, Ferrari A, Rey A, Oberlin O, Stevens MC, Kelsey A, Michalski J, Hawkins DS, Anderson JR.

Ann Oncol. 2014 Jan;25(1):231-6. doi: 10.1093/annonc/mdt426. Erratum in: Ann Oncol. 2014 Mar;25(3):756.

18.

Satisfaction with information used to choose prostate cancer treatment.

Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT.

J Urol. 2014 May;191(5):1265-71. doi: 10.1016/j.juro.2013.12.008. Epub 2013 Dec 12.

19.

PGE 2 desensitizes β -agonist effect on human lung fibroblast-mediated collagen gel contraction through upregulating PDE4.

Fang Q, Ma Y, Wang J, Michalski J, Rennard SI, Liu X.

Mediators Inflamm. 2013;2013:145197. doi: 10.1155/2013/145197. Epub 2013 Oct 8.

20.

Structure, vibrational spectra and DFT characterization of the intra- and inter-molecular interactions in 2-hydroxy-5-methylpyridine-3-carboxylic acid--normal modes of the eight-membered HB ring.

Godlewska P, Jańczak J, Kucharska E, Hanuza J, Lorenc J, Michalski J, Dymińska L, Węgliński Z.

Spectrochim Acta A Mol Biomol Spectrosc. 2014;120:304-13. doi: 10.1016/j.saa.2013.09.130. Epub 2013 Oct 10.

PMID:
24184924
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk